Every telehealth platform issuing prescriptions must employ physicians or nurse practitioners licensed in the patients state
these medications are a combination of GLP-1 plus gastric inhibitory polypeptide agonist (GIP) Semaglutide and tirzepatide are marketed for Type 2 diabetes and weight management under different brand names
TDP is committed to sharing accurate, science-based information and working with the American Autonomic Society (AAS) to make sure our message is scientifically valid, and it gets into the hands of those who need it most
Longer-term data consistently shows recovery
Rosenstock J, Marx N, Neubacher D, Seck T, Patel S, Woerle HJ, Johansen OE
*Correspondence: Sayna Norouzi, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers